These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 26455038

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease.
    Alcocer F, Novak Z, Combs BR, Lowman B, Passman MA, Mujib M, Jordan WD.
    J Vasc Surg; 2014 Apr; 59(4):950-5. PubMed ID: 24491238
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
    Moussa ID, Colombo A.
    Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1047-54. PubMed ID: 19626692
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery.
    Cardiac Society of Australia and New Zealand.
    Heart Lung Circ; 2010 Jan 01; 19(1):2-10. PubMed ID: 20045378
    [No Abstract] [Full Text] [Related]

  • 52. [Sudden edema and pain in the knee].
    Remes V, Helenius I.
    Duodecim; 2003 Jan 01; 119(17):1675, 1677. PubMed ID: 14587449
    [No Abstract] [Full Text] [Related]

  • 53. Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: a meta-analysis of randomized controlled trials.
    Sakurai R, Koo BK, Kaneda H, Bonneau HN, Nagai R.
    Int J Cardiol; 2013 Sep 01; 167(5):2250-8. PubMed ID: 22727963
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Management of Antiplatelet Allergy After Cardiac Stenting.
    Fett N.
    JAMA Dermatol; 2016 Oct 01; 152(10):1169-1170. PubMed ID: 27332824
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
    Wang TH, Bhatt DL, Fox KA, Steinhubl SR, Brennan DM, Hacke W, Mak KH, Pearson TA, Boden WE, Steg PG, Flather MD, Montalescot G, Topol EJ, CHARISMA Investigators.
    Eur Heart J; 2007 Sep 01; 28(18):2200-7. PubMed ID: 17673448
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.